<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1722">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05138744</url>
  </required_header>
  <id_info>
    <org_study_id>EMA1</org_study_id>
    <nct_id>NCT05138744</nct_id>
  </id_info>
  <brief_title>Behavioral Activation for Depression Through Virtual Reality</brief_title>
  <official_title>Behavioral Activation for Depression Through Virtual Reality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitat Jaume I</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitat Jaume I</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the effectiveness of a brief, virtual reality intervention for depressed mood&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 5, 2021</start_date>
  <completion_date type="Anticipated">February 20, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 22, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single case design (multiple baselines)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Behavioral activation</measure>
    <time_frame>Change through study completion, an average of 31 days. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline vs posttreatment)</time_frame>
    <description>In a scale from 0 (not at all) to 6 (completely), &quot;to what extent were you satisfied with what you did today?&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Mood</measure>
    <time_frame>Change through study completion, an average of 31 days. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)</time_frame>
    <description>In a scale from 0 (completely sad) to 100 (completely happy), &quot;how did you feel today?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Depression</measure>
    <time_frame>Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)</time_frame>
    <description>In a scale from 0 (not at all) to 3 (completely), &quot;how was your level of depression today?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Positive affect</measure>
    <time_frame>Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)</time_frame>
    <description>In a scale from 1 (not at all) to 5 (completely), &quot;how was your positive affect today?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Negative affect</measure>
    <time_frame>Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)</time_frame>
    <description>In a scale from 1 (not at all) to 5 (completely), &quot;how was your negative affect today?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Activity level</measure>
    <time_frame>Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)</time_frame>
    <description>In a scale from 0 (minimum) to 100 (maximum), &quot;what was your activity level today?&quot;</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Virtual reality treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of google maps with virtual reality to virtually situate the participants into scenarios that are motivating for them (i.e., the beach, a mountain, a park, etc.) at their choice.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Behavioral activation using virtual reality</intervention_name>
    <description>The investigators will encourage behavioral activation (increase in the number and time of conducted activities) situating the person in motivating situations using virtual reality</description>
    <arm_group_label>Virtual reality treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient Health Questionnaire - 9 (measure of depression) over 9&#xD;
&#xD;
          -  Positive and Negative Affect Schedule (measure of positive and negative affect):&#xD;
             positive affect score below 24&#xD;
&#xD;
          -  Age over 18 years&#xD;
&#xD;
          -  Signs informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Completes more than 20% of evaluations retrospectively (not the day they are assigned)&#xD;
&#xD;
          -  Has a severe mental health disorder as evaluated with the MINI International&#xD;
             Neuropsychiatric Interview&#xD;
&#xD;
          -  Does not sign the informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Desir√©e Colombo, PhD</last_name>
    <phone>964 387648</phone>
    <email>dcolombo@uji.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carlos Suso, PhD</last_name>
    <email>susor@uji.es</email>
  </overall_contact_backup>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 26, 2021</study_first_submitted>
  <study_first_submitted_qc>November 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2021</study_first_posted>
  <last_update_submitted>November 30, 2021</last_update_submitted>
  <last_update_submitted_qc>November 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be anonymized and will only be shared upon reasonable request without identifying information</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

